Phase III Double-blind, Placebo-controlled Study of AZD7442 for Pre-exposure Prophylaxis of COVID-19 in Adult. (PROVENT): Worth Considering for any Chronic Lymphocytic Leukemia (CLL) Patient
Take it with you! CLL Society’s Official COVID-19 Triage Statement
CLL Society has authored an Official Statement to help you help your healthcare providers understand CLL patients’ unique vulnerabilities to COVID-19 and our higher risks of serious complications.
This letter to your healthcare provider may help you be attended to faster, should you have any COVID-19 symptoms or worries or want early access to the SARS-CoV-2 vaccine.
COVID-19 concerns are topline in medical offices these days and the demands for care can overwhelm some medical facilities, so triaging who gets attention becomes a necessity. Likewise vaccine supplies will be limited at first and experts agree that we should be at top of list of those most vulnerable. Fax, email, or otherwise draw your provider’s attention to this letter!
The CLL Society is invested in your long life. Please invest in the long life of the CLL Society.
Related posts